Skip to content
10-Q

Quarterly Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-15-031411

← back to feed
Filed
May 15, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · May 14, 2015 22.01M sh
Short Term Debt Q1 2015 · Mar 31, 2015 $110K
Short Term Debt Q1 2015 · Dec 31, 2014 $200K
Cash And Equivalents Q1 2015 · Mar 31, 2015 $56.03K
Cash And Equivalents Q1 2015 · Dec 31, 2014 $12.51K
Cash And Equivalents Q1 2015 · Mar 31, 2014 $29.87K
Cash And Equivalents Q1 2015 · Dec 31, 2013 $44.9K
Stockholders Equity Q1 2015 · Mar 31, 2015 −$5.94M
Stockholders Equity Q1 2015 · Dec 31, 2014 −$5.66M
Current Liabilities Q1 2015 · Mar 31, 2015 $5.3M
Current Liabilities Q1 2015 · Dec 31, 2014 $4.98M
Total Liabilities Q1 2015 · Mar 31, 2015 $6M
Total Liabilities Q1 2015 · Dec 31, 2014 $5.68M
Current Assets Q1 2015 · Mar 31, 2015 $56.03K
Current Assets Q1 2015 · Dec 31, 2014 $12.51K
Total Assets Q1 2015 · Mar 31, 2015 $56.03K
Total Assets Q1 2015 · Dec 31, 2014 $12.51K
Sga Expense Q1 2015 · Mar 31, 2015 $111.92K
Sga Expense Q1 2015 · Mar 31, 2014 $95.07K
Rd Expense Q1 2015 · Mar 31, 2015 $160.91K
Rd Expense Q1 2015 · Mar 31, 2014 $150.27K
Net Income Q1 2015 · Mar 31, 2015 −$277.49K
Net Income Q1 2015 · Mar 31, 2014 −$307.36K
Revenue Q1 2015 · Mar 31, 2015 $0
Revenue Q1 2015 · Mar 31, 2014 $0